83
Participants
Start Date
March 16, 2022
Primary Completion Date
January 24, 2024
Study Completion Date
January 24, 2025
OTX-TIC low dose Travoprost Intracameral Implant
OTX-TIC implant is injected into the anterior chamber of the eye.
OTX-TIC high dose Travoprost Intracameral Implant
OTX-TIC implant is injected into the anterior chamber of the eye.
Durysta, Bimatoprost Intracameral Implant 10 µg
Durysta is injected into the anterior chamber of the eye.
Ocular Therapeutix, Inc., Troy
Ocular Therapeutix, Inc., Cranberry Township
Ocular Therapeutix, Inc., Philadelphia
Ocular Therapeutix, Inc., Durham
Ocular Therapeutix, Inc., Roswell
Ocular Therapeutiux, Inc., Delray Beach
Ocular Therapeutix, Inc., Clearwater
Ocular Therapeutix, Inc., Fort Myers
Ocular Therapeutix, Inc., Dothan
Ocular Therapeutix, Inc., Cleveland
Ocular Therapeutix Inc, Carmel
Ocular Therapeutix, Inc., Saint Joseph
Ocular Therapeutix, Inc., Saint Joseph
Ocular Therapeutix, Inc., Kenosha
Ocular Therapeutiux, Inc., Fargo
Ocular Therapeutix, Inc., Rock Island
Ocular Therapeutix Inc., St Louis
Ocular Therapeutix Inc, Oklahoma City
Ocular Therapeutix, Inc., Dallas
Ocular Therapeutix, Inc., Houston
Ocular Therapeutix, Inc., Austin
Ocular Therapeutix, Inc., El Paso
Ocular Therapeutix, Inc., Los Angeles
Ocular Therapeutix, Inc., Torrance
Ocular Therapeutix, Inc., Pasadena
Ocular Therapeutix, Inc., Redlands
Ocular Therapeutix, Inc., Irvine
Ocular Therapeutix, Inc., Huntington Beach
Ocular Therapeutix, Inc., Petaluma
Ocular Therapeutix, Inc., Dover
Lead Sponsor
Ocular Therapeutix, Inc.
INDUSTRY